In addition to providing mechanistic insights, CAFs and CD163+ macrophages (M2) may also prove to be potential prognostic predictors; since expressions of CAF and M2 macrophage markers are correlated with poor prognosis in colorectal cancer and oral squamous cell carcinoma (252, 253). Here, CD163 is linked to colorectal cancer.